Pharmacokinetics, Pharmacodynamics, and Safety Study of Ticagrelor in Hemodialysis Patients and Healthy Subjects
Status:
Completed
Trial end date:
2016-05-09
Target enrollment:
Participant gender:
Summary
A phase I, open-label study comparing the pharmacokinetics, pharmacodynamics, safety and
tolerability of ticagrelor in hemodialysis patients to healthy subjects with normal renal
function.